"Owensboro Heart & Vascular is a leading facility with advanced diagnostics services and medical treatments for all your heart vein and artery related health problems. Interventional cardiologists, Dr. Kishor Vora and Dr. Lior Shamai, along with a team of nurse practitioners are accepting new patients. We offer coronary and cardiac consultations and interventions. Our physicians with cardiovascular expertise, also offer peripheral vascular disease management and interventions. Our Coumadin Clinic monitors patients undergoing therapy with anticoagulant drugs and helps them safely and effectively manage their dosage. Our Device Clinic offers comprehensive management for cardiac rhythm devices like loop recorder, pacemaker and defibrillators."

During the past decade, Owensboro Heart & Vascular conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Owensboro Heart & Vascular" #1 collaborator was "Medtronic" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Owensboro Heart & Vascular" are "Myocardial Infarction" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Owensboro Heart & Vascular" in a lesser frequency.

Most popular intervention types in "Owensboro Heart & Vascular" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Placebo" (1 trials), "Plavix (clopidogrel 75 mg) and aspirin" (1 trials) and "Targeted Renal Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Owensboro Heart & Vascular" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Owensboro Heart & Vascular". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Owensboro Heart & Vascular, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Owensboro Heart & Vascular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".